Serena Pelusi

3.9k total citations
42 papers, 1.1k citations indexed

About

Serena Pelusi is a scholar working on Epidemiology, Hepatology and Hematology. According to data from OpenAlex, Serena Pelusi has authored 42 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Epidemiology, 14 papers in Hepatology and 8 papers in Hematology. Recurrent topics in Serena Pelusi's work include Liver Disease Diagnosis and Treatment (29 papers), Liver Disease and Transplantation (8 papers) and Iron Metabolism and Disorders (7 papers). Serena Pelusi is often cited by papers focused on Liver Disease Diagnosis and Treatment (29 papers), Liver Disease and Transplantation (8 papers) and Iron Metabolism and Disorders (7 papers). Serena Pelusi collaborates with scholars based in Italy, Sweden and Finland. Serena Pelusi's co-authors include Luca Valenti, Paola Dongiovanni, Silvia Fargion, Raffaela Rametta, Anna Ludovica Fracanzani, Stefano Romeo, Daniele Prati, Marica Meroni, Guido Baselli and Benedetta Maria Motta and has published in prestigious journals such as PLoS ONE, Hepatology and Gut.

In The Last Decade

Serena Pelusi

39 papers receiving 1.0k citations

Peers

Serena Pelusi
S. Ferri Italy
Erik J. M. Toonen Netherlands
Hidetaka Shibata Japan
Guido Baselli Italy
Jun Soma Japan
Liu Yl China
Yii-Der Ida Chen United States
Shiva Kumar Shanmukhappa United States
Hiromu Kawahara Japan
Bernard Silver United States
S. Ferri Italy
Serena Pelusi
Citations per year, relative to Serena Pelusi Serena Pelusi (= 1×) peers S. Ferri

Countries citing papers authored by Serena Pelusi

Since Specialization
Citations

This map shows the geographic impact of Serena Pelusi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Serena Pelusi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Serena Pelusi more than expected).

Fields of papers citing papers by Serena Pelusi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Serena Pelusi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Serena Pelusi. The network helps show where Serena Pelusi may publish in the future.

Co-authorship network of co-authors of Serena Pelusi

This figure shows the co-authorship network connecting the top 25 collaborators of Serena Pelusi. A scholar is included among the top collaborators of Serena Pelusi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Serena Pelusi. Serena Pelusi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pelusi, Serena, Misty Saracino, Salvatore Petta, et al.. (2025). Carriage of rare pathogenic apob variants predispose to severe masld and hcc. Digestive and Liver Disease. 57. S64–S65.
2.
Pelusi, Serena, Luisa Ronzoni, Chiara Rosso, et al.. (2024). Prevalence and Determinants of Liver Disease in Relatives of Italian Patients With Advanced MASLD. Clinical Gastroenterology and Hepatology. 22(11). 2231–2239.e4. 7 indexed citations
3.
Pelusi, Serena, Cristiana Bianco, Massimo Colombo, et al.. (2023). Metabolic dysfunction outperforms ultrasonographic steatosis to stratify hepatocellular carcinoma risk in patients with advanced hepatitis C cured with direct‐acting antivirals. Liver International. 43(7). 1593–1603. 7 indexed citations
4.
Ronzoni, Luisa, Francesco Malvestiti, Cristiana Bianco, et al.. (2023). Liver Involvement in Patients with Rare MBOAT7 Variants and Intellectual Disability: A Case Report and Literature Review. Genes. 14(8). 1633–1633. 2 indexed citations
5.
Tomasi, Melissa, Alessandro Cherubini, Serena Pelusi, et al.. (2023). Circulating Interlukin-32 and Altered Blood Pressure Control in Individuals with Metabolic Dysfunction. International Journal of Molecular Sciences. 24(8). 7465–7465. 7 indexed citations
6.
Bianco, Cristiana, Serena Pelusi, Federica Tavaglione, et al.. (2023). Predictors of controlled attenuation parameter in metabolic dysfunction. United European Gastroenterology Journal. 12(3). 364–373. 5 indexed citations
7.
Mantovani, Alessandro, Serena Pelusi, Francesco Malvestiti, et al.. (2023). Adverse effect of PNPLA3 p.I148M genetic variant on kidney function in middle‐aged individuals with metabolic dysfunction. Alimentary Pharmacology & Therapeutics. 57(10). 1093–1102. 11 indexed citations
8.
Valenti, Luca, Armando Tripodi, Vincenzo La Mura, et al.. (2022). Clinical and genetic determinants of the fatty liver–coagulation balance interplay in individuals with metabolic dysfunction. JHEP Reports. 4(12). 100598–100598. 17 indexed citations
9.
Pelusi, Serena, Luisa Ronzoni, Francesco Malvestiti, et al.. (2022). Clinical exome sequencing for diagnosing severe cryptogenic liver disease in adults: A case series. Liver International. 42(4). 864–870. 11 indexed citations
10.
Meroni, Marica, Paola Dongiovanni, Miriam Longo, et al.. (2020). Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes. EBioMedicine. 52. 102658–102658. 66 indexed citations
11.
Baselli, Guido, Paola Dongiovanni, Raffaela Rametta, et al.. (2020). Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker. Gut. 69(10). 1855–1866. 75 indexed citations
12.
Pelusi, Serena, Annalisa Cespiati, Raffaela Rametta, et al.. (2019). Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis. Clinical Gastroenterology and Hepatology. 17(11). 2310–2319.e6. 65 indexed citations
13.
Dongiovanni, Paola, Marica Meroni, Guido Baselli, et al.. (2019). PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients. Journal of Lipid Research. 60(6). 1144–1153. 44 indexed citations
14.
Dongiovanni, Paola, Marica Meroni, Rosellina Margherita Mancina, et al.. (2018). Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease. Hepatology Communications. 2(6). 666–675. 35 indexed citations
15.
Pelusi, Serena, Salvatore Petta, Chiara Rosso, et al.. (2016). Renin-Angiotensin System Inhibitors, Type 2 Diabetes and Fibrosis Progression: An Observational Study in Patients with Nonalcoholic Fatty Liver Disease. PLoS ONE. 11(9). e0163069–e0163069. 64 indexed citations
16.
Canavesi, Elena, Massimiliano Ruscica, Raffaela Rametta, et al.. (2015). Increased circulating adiponectin in males with chronic HCV hepatitis. European Journal of Internal Medicine. 26(8). 635–639. 8 indexed citations
17.
Pelusi, Serena, Raffaela Rametta, Claudia Della Corte, et al.. (2014). Juvenile hemochromatosis associated with heterozygosity for novel hemojuvelin mutations and with unknown cofactors. Annals of Hepatology. 13(5). 568–571. 3 indexed citations
18.
Pelusi, Serena, Domenico Girelli, Raffaela Rametta, et al.. (2013). The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis. BMC Nephrology. 14(1). 48–48. 19 indexed citations
19.
Valenti, Luca, Anna Ludovica Fracanzani, Raffaela Rametta, et al.. (2012). Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosis. Journal of Hepatology. 57(6). 1319–1325. 25 indexed citations
20.
Valenti, Luca, Raffaela Rametta, Paola Dongiovanni, et al.. (2012). The A736V TMPRSS6 Polymorphism Influences Hepatic Iron Overload in Nonalcoholic Fatty Liver Disease. PLoS ONE. 7(11). e48804–e48804. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Ferri Breakdown of academic impact, for papers by Erik J. M. Toonen Breakdown of academic impact, for papers by Hidetaka Shibata Breakdown of academic impact, for papers by Guido Baselli Breakdown of academic impact, for papers by Jun Soma Breakdown of academic impact, for papers by Liu Yl Breakdown of academic impact, for papers by Yii-Der Ida Chen Breakdown of academic impact, for papers by Shiva Kumar Shanmukhappa Breakdown of academic impact, for papers by Hiromu Kawahara Breakdown of academic impact, for papers by Bernard Silver
Rankless by CCL
2026